Nuvation Bio NUVB Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's cash provided by (used in) investing activity, including discontinued operation?
- Nuvation Bio (NUVB) reported cash provided by (used in) investing activity, including discontinued operation of -$43.64M in Q1 2026.
- How has Nuvation Bio's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Nuvation Bio's cash provided by (used in) investing activity, including discontinued operation decreased by 180.5% year-over-year, from $54.18M to -$43.64M.
- What is the long-term trend for Nuvation Bio's cash provided by (used in) investing activity, including discontinued operation?
- Over 2 years (2021 to 2024), Nuvation Bio's cash provided by (used in) investing activity, including discontinued operation has grown at a -48.1% compound annual growth rate (CAGR), from -$454.67M to $122.7M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.